ACCD - Why Healthcare Technology Company Accolade Shares Are Surging Today | Benzinga
Accolade Inc (NASDAQ: ACCD) shares are trading higher after the company announced Q3 FY24 results yesterday.
The company reported a revenue increase of 9% to $99.4 million, beating the consensus of $96.2 million.
Adjusted gross profit rose 10% Y/Y to $46.0 million. Adjusted EBITDA loss narrowed to $(4.6) million from $(10.2) million a year ago.
EPS loss of $(0.28) beat the consensus of loss of $(0.44).
As of November 2023, ACCD's cash and cash equivalents stood at $230.0 million.
Outlook: The company expects Q4 revenues of $121.5 million-$125.5 million (vs. $126.33 million estimate) and adjusted ...